Interferon Responsiveness Does Not Change in Treatment-Experienced Hepatitis C Subjects: Implications for Drug Development and Clinical Decisions | Zendy

Jiang Liu | Zendy; J Florian | Zendy; Debra Birnkrant | Zendy; Jeffrey S. Murray | Zendy; Pravin Jadhav | Zendy

Open Access

Interferon Responsiveness Does Not Change in Treatment-Experienced Hepatitis C Subjects: Implications for Drug Development and Clinical Decisions

Author(s) -

Jiang Liu,

J Florian,

Debra Birnkrant,

Jeffrey S. Murray,

Pravin Jadhav

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis510

Subject(s) - medicine , ribavirin , regimen , clinical trial , hepatitis c , interferon , immunology , chronic hepatitis , gastroenterology , virus

The purpose of this research was to compare interferon (IFN) responsiveness in treatment-naive and pegylated interferon α-ribavirin (P/R)-experienced subjects and to understand the implications of comparability in IFN responsiveness across treatment courses on drug development and clinical decision making.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research